News

New stroke risk reduction technology designed to advance procedural performance and safety, treat wider range of patients with non-valvular atrial fibrillation Boston Scientific Corporation announced it has received U.S. Food and Drug...

Preventice Solutions, a leader in digital healthcare solutions and remote cardiac monitoring services powered by deep learning and artificial intelligence (AI), announced that it has raised $137M in a Series B financing to accelerate...

The United States Food and Drug Administration (FDA) has approved one-way digital data streaming during patient support from Abiomed's Automated Impella Controller (AIC), the external console used with Impella heart pumps. The data streaming...

GS Elektromedizinische Geraete G. Stemple GmbH, marketing defibrillators under the corpuls brand, and VectraCor Inc., announced that they have concluded a licensing agreement allowing corpuls to incorporate VectraCor's cloud-based version...

The University of Pittsburgh and Vivasc Therapeutics Inc. announced a research grant awarded by the NIH National Heart, Lung, and Blood Institute, valued at approximately $327,000 for the continued development of CTP-amio, the company’s lead...

Innovative Health, Inc. announced two milestones that further strengthen the company's competitive edge within the medical device reprocessing field. In early July, Innovative Health was certified under the Medical Device Single Audit Program...

AstraZeneca has been granted Fast Track Designation in the U.S. for the development of FARXIGA® (dapagliflozin) to reduce the risk of hospitalization for heart failure (hHF) or cardiovascular (CV) death in adults following an acute myocardial...

A drug used to treat systemic lupus erythematosus (SLE) significantly reduces the incidence of a rare and sometimes fatal heart condition in newborn babies, a new study from NYU Grossman School of Medicine researchers shows. The condition,...

Vitls Inc. announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Vitls Platform. The Vitls Platform utilizes a single device to continuously and remotely monitor the vital signs clinicians need...